Efficacy and Safety of TV-1380 as Treatment for Facilitation of Abstinence in Cocaine-Dependent Subjects



Status:Completed
Conditions:Psychiatric, Pulmonary
Therapuetic Areas:Psychiatry / Psychology, Pulmonary / Respiratory Diseases
Healthy:No
Age Range:18 - 60
Updated:4/21/2016
Start Date:June 2013
End Date:October 2014

Use our guide to learn which trials are right for you!

A 12-week, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Once-Weekly Intra-Muscular Injections of TV-1380 (150 mg/Week or 300 mg/Week) as Treatment for Facilitation of Abstinence in Cocaine-Dependent Subjects

The primary objective of this study is to assess the efficacy and safety of TV-1380
[Recombinant human serum albumin (HSA) mutated butyrylcholinesterase (AlbuBChE)] in
facilitating abstinence in cocaine-dependent subjects.


Inclusion Criteria:

- Have the ability to understand, and having understood, provide written informed
consent to comply with the treatment protocol.

- Male or female aged 18-60 years (inclusive).

- Meet Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition.

- Other criteria apply; please contact the site for more information.

Exclusion Criteria:

- Meet criteria for current dependence on any psychoactive substance other than
cocaine, alcohol, nicotine, benzodiazepines, or marijuana OR have physiological
dependence on alcohol requiring detoxification.

- Are currently treated with an opiate-substitute (buprenorphine or methadone)
maintenance treatment or received therapy with any opiate-substitute within 90 days
preceding screening.

- Have one or more severe psychiatric disorders as determined by the Mini International
Neuropsychiatric Interview (MINI) such as psychosis, schizophrenia, bipolar disease,
major depression, or eating disorders in screening.

- Have one or more major neurologic disorders such as dementia or organic brain
disease.

- Have other serious medical illnesses (including but not limited to uncontrolled
hypertension, significant heart disease, respiratory disease including asthma,
hepatic disease, renal disease, AIDS) or other potentially life threatening or
progressive medical illness that may compromise subject safety or study conduct as
determined by the site MD.

- Other criteria apply; please contact the site for more information.
We found this trial at
15
sites
?
mi
from
Alicante,
Click here to add this to my saved trials
Boston, Massachusetts
?
mi
from
Boston, MA
Click here to add this to my saved trials
Charleston, South Carolina
?
mi
from
Charleston, SC
Click here to add this to my saved trials
Columbus, Ohio
?
mi
from
Columbus, OH
Click here to add this to my saved trials
?
mi
from
Las Vagas, NV
Click here to add this to my saved trials
Los Angeles, California
?
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Marlton, New Jersey
?
mi
from
Marlton, NJ
Click here to add this to my saved trials
New Bedford, Massachusetts
?
mi
from
New Bedford, MA
Click here to add this to my saved trials
North Miami, Florida
?
mi
from
North Miami, FL
Click here to add this to my saved trials
Oceanside, California
?
mi
from
Oceanside, CA
Click here to add this to my saved trials
Pittsburgh, Pennsylvania
?
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Salt Lake City, Utah
?
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
San Francisco, California
?
mi
from
San Francisco, CA
Click here to add this to my saved trials
St Louis, Missouri
?
mi
from
St Louis, MO
Click here to add this to my saved trials
Torrance, California
?
mi
from
Torrance, CA
Click here to add this to my saved trials